AzTrials
AzTrials

Adenoma Detection RateTraCoNCT01786213

Training Effects in Colonoscopy

An observational study of Adenoma Detection Rate, run by Technical University of Munich at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Colon cancer is the second most common cause of death among cancer-related deaths in Germany. Precancerous lesions such as adenomas can be detected efficiently by colonoscopy. To provide high quality in colonoscopy several quality parameters have been postulated in the past. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Adenoma Detection Rate
How many people
3,500 participants
Where
1 siteGermany
Study dates
Feb 2013to Jan 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Endoscopy Department of a university Hospital

Who may be able to join

  • colonoscopy performed at the Technical University Munich, Germany

Who cannot join

  • colonoscopy performed for the purpose of polypectomy

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Medizinische Klinik und Poliklinik der Technischen Universität München

    Munich, Bavaria, 81675

Other trials in Germany

About this study

Official title: The Impact of Training Effects on Quality Indicators in Colonoscopy: a Retrospective Study.

Colon cancer is the second most common cause of death among cancer-related deaths in Germany. Precancerous lesions such as adenomas can be detected efficiently by colonoscopy. To provide high quality in colonoscopy several quality parameters have been postulated in the past. The adenoma detection rate (ADR) is one of those parameters. Empirical data suggest that a detection rate of 20% should be demanded. Detection rates are influenced by a multitude of circumstances such as bowel cleanness. The facts that detection rates vary between colonoscopists suggests that leaning effects may also play a role. It is not known how ADR and other quality parameters evolve while trainees improve their skills in colonoscopy. The investigators postulate that a learning curve exists. The investigators therefore plan to evaluate chronologically the findings of trainee colonoscopists. A particular performance in detecting adenomas shall be calculated in relation to the amount of examinations performed.

Keywords
adenoma detection rate, colonoscopy, trainee, learning curve

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01786213
Study groupRoleWhat they receive
Colonoscopist ANot described
Colonoscopist BNot described
Colonoscopist CNot described
Colonoscopist DNot described
Colonoscopist ENot described
Colonoscopist FNot described
Colonoscopist GNot described
Colonoscopist HNot described
Colonoscopist INot described
Colonoscopist JNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adenoma detection rate

    While numbers of investigations rise new detection rates are calculated for each colonoscopist.

    Measured: every 50 examinations

Secondary outcomes (1)
  1. Polyp detection rate

    Measured: every 50 examinations

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2013 (estimated)
  2. Study startFeb 2013
  3. Primary completionJan 2014
  4. Study completionJan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Retrospective
Enrolment
3,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01786213
Sponsor's protocol ID
TraCo
Acronym
TraCo
Status last verified
Feb 2013
First submitted
5 Feb 2013
Last updated
6 Feb 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Adenoma Detection Rate, run by Technical University of Munich at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adenoma detection rate (time frame: every 50 examinations). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in